Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme

Clinical trial NCT00021307 · WITHDRAWN

Trial details

NCT number: NCT00021307
Sponsor: Fox Chase Cancer Center
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Primary completion: 2002-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.